Cancer Research, Statistics, and Treatment (Jan 2024)
A personalized approach to the management of rare genetic aberrations in oncology: A letter citing the EGFR exon 18 mutation molecular tumor board report
Abstract
No abstracts available.
Cancer Research, Statistics, and Treatment (Jan 2024)